G Judmaier
Overview
Explore the profile of G Judmaier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
785
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Schutze K, Brandstatter G, Dragosics B, Judmaier G, Hentschel E
Aliment Pharmacol Ther
. 1997 Apr;
11(2):387-94.
PMID: 9146780
Aim: To study the effect of prokinetic treatment with cisapride in patients with constipation-predominant irritable bowel syndrome. Patients And Methods: Ninety-six patients were randomly assigned to treatment with either cisapride...
12.
Ringler M, Sturm W, Kathrein H, Judmaier G
Ultraschall Med
. 1997 Feb;
18(1):31-4.
PMID: 9173525
Introduction: The clinical significance of the sonographic finding "periportal hyperechogenicity", which is characterized by hard periportal echoes, is largely undetermined. This phenomenon has been reported in a large number of...
13.
Ferenci P, Stauber R, PROPST A, Fiedler R, Muller C, Gschwantler M, et al.
Dig Dis Sci
. 1996 Dec;
41(12 Suppl):103S-108S.
PMID: 9011466
Approximately 50% of patients with chronic hepatitis C respond to treatment with interferon-alpha. The aim of this randomized controlled trial was to evaluate whether an increase in dose of interferon-alpha...
14.
Umlauft F, Keeffe E, Offner F, Weiss G, Feichtinger H, Lehmann E, et al.
Am J Gastroenterol
. 1996 Oct;
91(10):2135-8.
PMID: 8855736
Objectives: Blood group antigens traditionally have been associated with a risk of developing peptic ulcer and gastric cancer. Helicobacter pylori is a bacterium associated with chronic active gastritis and ulcer...
15.
PROPST A, Propst T, Judmaier G
Arzneimittelforschung
. 1996 Jun;
46(6):621-4.
PMID: 8767354
In previous studies measuring intragastric pH in healthy volunteers it was shown that there was a faster onset of action with ranitidine (CAS 66357-35-5) 300 mg effervescent tablets (Zantac) compared...
16.
Propst T, PROPST A, Judmaier G, Vogel W
Dtsch Med Wochenschr
. 1996 Mar;
121(9):280-4.
PMID: 8681776
No abstract available.
17.
PROPST A, Propst T, Waldenberger P, Judmaier G, Vogel W
Schweiz Med Wochenschr
. 1995 Nov;
125(44):2137-42.
PMID: 7502013
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. The profile of risk factors associated with HCC includes not only chronic infection with hepatitis B...
18.
PROPST A, Propst T, Herold M, Vogel W, Judmaier G
Eur J Gastroenterol Hepatol
. 1995 Nov;
7(11):1031-6.
PMID: 8680901
Background: Immunoregulatory properties of cytokines may mediate disordered inflammatory events in inflammatory bowel diseases (IBDs). On the basis of data obtained in experimental colitis, the hypothesis has been advanced that...
19.
PROPST A, Propst T, Ofner D, Feichtinger H, Judmaier G, Vogel W
Scand J Gastroenterol
. 1995 Nov;
30(11):1108-12.
PMID: 8578172
Background: Alpha-1-antitrypsin deficiency is a common autosomal recessive disorder associated with early development of emphysema, liver cirrhosis, and hepatocellular carcinoma. The aim of the present study was to define prognosis...
20.
PROPST A, Propst T, Zangerl G, Ofner D, Judmaier G, Vogel W
Dig Dis Sci
. 1995 Aug;
40(8):1805-15.
PMID: 7648984
The aim of the present was to define prognosis and life expectancy in patients with chronic liver disease of different etiologies and to relate them to an age- and sex-matched...